ACLX
Price
$68.81
Change
-$1.47 (-2.09%)
Updated
Dec 2 closing price
Capitalization
4.06B
85 days until earnings call
Intraday BUY SELL Signals
PLX
Price
$1.67
Change
-$0.03 (-1.76%)
Updated
Dec 2 closing price
Capitalization
136.72M
99 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACLX vs PLX

Header iconACLX vs PLX Comparison
Open Charts ACLX vs PLXBanner chart's image
Arcellx
Price$68.81
Change-$1.47 (-2.09%)
Volume$1.08M
Capitalization4.06B
Protalix BioTherapeutics
Price$1.67
Change-$0.03 (-1.76%)
Volume$638.47K
Capitalization136.72M
ACLX vs PLX Comparison Chart in %
ACLX
Daily Signal:
Gain/Loss:
PLX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACLX vs. PLX commentary
Dec 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and PLX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 03, 2025
Stock price -- (ACLX: $68.81 vs. PLX: $1.67)
Brand notoriety: ACLX and PLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 151% vs. PLX: 76%
Market capitalization -- ACLX: $4.06B vs. PLX: $136.72M
ACLX [@Biotechnology] is valued at $4.06B. PLX’s [@Biotechnology] market capitalization is $136.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whilePLX’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • PLX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACLX and PLX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 5 TA indicator(s) are bullish while PLX’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 5 bullish, 5 bearish.
  • PLX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PLX is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -5.74% price change this week, while PLX (@Biotechnology) price change was -6.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.91%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +52.68%.

Reported Earning Dates

ACLX is expected to report earnings on Feb 26, 2026.

PLX is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-1.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.06B) has a higher market cap than PLX($137M). ACLX YTD gains are higher at: -10.275 vs. PLX (-11.170). PLX has higher annual earnings (EBITDA): 10.4M vs. ACLX (-179.78M). ACLX has more cash in the bank: 453M vs. PLX (33.4M). PLX has less debt than ACLX: PLX (5.35M) vs ACLX (52.5M). PLX has higher revenues than ACLX: PLX (61.9M) vs ACLX (57M).
ACLXPLXACLX / PLX
Capitalization4.06B137M2,966%
EBITDA-179.78M10.4M-1,729%
Gain YTD-10.275-11.17092%
P/E RatioN/A20.88-
Revenue57M61.9M92%
Total Cash453M33.4M1,356%
Total Debt52.5M5.35M981%
FUNDAMENTALS RATINGS
PLX: Fundamental Ratings
PLX
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
51
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXPLX
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 17 days ago
87%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 8 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signal:
Gain/Loss:
PLX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCKRF42.990.04
+0.09%
Teck Resources Ltd.
QRNNF2.45N/A
N/A
Aurizon Holdings Ltd.
MDTWF2.15N/A
N/A
Mediterranean Towers LTD
RAFA0.04N/A
-2.65%
Rafarma Pharmaceuticals, Inc. (WY)
ORRCF0.19-0.01
-7.05%
Oroco Resource Corp.

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-2.09%
CGON - ACLX
50%
Loosely correlated
-4.35%
ROIV - ACLX
47%
Loosely correlated
-0.59%
XNCR - ACLX
46%
Loosely correlated
-3.15%
KRYS - ACLX
45%
Loosely correlated
-0.02%
CRNX - ACLX
45%
Loosely correlated
-0.53%
More